BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26552190)

  • 1. [Discussion about risk and management of Chinese patent medicine with double identity].
    Jin Y; Wu SW; Gao XW; Xu DH; Zhai YS
    Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(11):2249-51. PubMed ID: 26552190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Based on the Beers Criteria 2019 Edition Over-the-Counter Drugs Risk Confirmation of Elderly Chinese.
    Yang Y; Zhang L; Huang Y; Huang H; Sun S; Xiao J
    Biomed Res Int; 2021; 2021():5524551. PubMed ID: 34485515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
    Hanna LA; Hughes C
    Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Summary and analysis of safety warning on clinical application of anti-cold Chinese patent medicine preparations].
    Lai XX; Lin H; Luo YN; Wang YY; Duan XH; Wang L; Luo R; Chen YH
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1594-600. PubMed ID: 26281605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Societal perspectives on over-the-counter (OTC) medicines.
    Wazaify M; Shields E; Hughes CM; McElnay JC
    Fam Pract; 2005 Apr; 22(2):170-6. PubMed ID: 15710640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thinking about evaluation of proprietary Chinese medicines containing toxic herbs during switch process of non-prescription drugs].
    Xia D; Cheng G; Li X; Zhou J; Xiao A; Zhang C; Du X
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3389-92. PubMed ID: 21438414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
    Yang W; Xie Y; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-the-counter medicines and the elderly.
    Barnett NL; Denham MJ; Francis SA
    J R Coll Physicians Lond; 2000; 34(5):445-6. PubMed ID: 11077655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of 'over-the-counter' medicinal products in on-line prescription records: a risk factor of overlooking interactions in the elderly.
    Olesen C; Harbig P; Barat I; Damsgaard EM
    Pharmacoepidemiol Drug Saf; 2013 Feb; 22(2):145-50. PubMed ID: 23097415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany.
    Eickhoff C; Hämmerlein A; Griese N; Schulz M
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):254-60. PubMed ID: 21953893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese patent medicine as a potential source of mercury poisoning.
    Kang-Yum E; Oransky SH
    Vet Hum Toxicol; 1992 Jun; 34(3):235-8. PubMed ID: 1609495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the question of special over-the-counter drugs].
    Kolár J
    Ceska Slov Farm; 2011 Dec; 60(6):269-75. PubMed ID: 22312849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application characteristics and situation analysis of volatile oils in database of Chinese patent medicine].
    Wang SJ; Wu ZF; Yang M; Wang YQ; Hu PY; Jie XL; Han F; Wang F
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3379-83. PubMed ID: 25522633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety risks of over-the-counter (OTC) drugs and their management.
    Veronika C; Aron F; Peter S
    Acta Pharm Hung; 2016; 86(4):151-159. PubMed ID: 29870601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-the-counter and prescription medicine misuse in Cape Town--findings from specialist treatment centres.
    Myers B; Siegfried N; Parry CD
    S Afr Med J; 2003 May; 93(5):367-70. PubMed ID: 12830601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions.
    Guirguis K
    Consult Pharm; 2010 Jul; 25(7):433-9. PubMed ID: 20601348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland--a retrospective evaluation.
    Wazaify M; Kennedy S; Hughes CM; McElnay JC
    J Clin Pharm Ther; 2005 Feb; 30(1):39-44. PubMed ID: 15659002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.